Age-Related Macular Degeneration / Choroidal Neovascularization / Genetic Counseling
University of Utah
The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degeneration (AMD), and to assess the impact of presymptomatic genetic testing for choroidal neovascularization (CNV).
- Behavioral: Early disclosure
- Behavioral: Late disclosure
|Ages eligible for Study||20 Years to 59 Years|
|Genders eligible for Study||All|
|Accepts Healthy Volunteers||Accepts Healthy Volunteers|
- Caucasian (this particular genetic test is only validated in Caucasians) Participants can have a positive family history of AMD but this is not necessary.
- Individuals with a personal history of AMD are not eligible. Non-caucasian individuals are not eligible. Employees of the Moran Eye Center are not eligible.
United States (1)
- University of Utah John A. Moran Eye CenterNot specifiedSalt Lake City, Utah, United States, 84132
active not recruiting
29 February, 2016
25 April, 2017